Clinical Trial Update: Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating TS-1 with concurrent radiotherapy for metastatic pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Pancreatic Cancer | Phase 1 | Status: TERMINATED